Controlled sulfur-based engineering confers mouldability to phosphorothioate antisense oligonucleotides
- PMID: 37099382
- PMCID: PMC10250214
- DOI: 10.1093/nar/gkad309
Controlled sulfur-based engineering confers mouldability to phosphorothioate antisense oligonucleotides
Abstract
Phosphorothioates (PS) have proven their effectiveness in the area of therapeutic oligonucleotides with applications spanning from cancer treatment to neurodegenerative disorders. Initially, PS substitution was introduced for the antisense oligonucleotides (PS ASOs) because it confers an increased nuclease resistance meanwhile ameliorates cellular uptake and in-vivo bioavailability. Thus, PS oligonucleotides have been elevated to a fundamental asset in the realm of gene silencing therapeutic methodologies. But, despite their wide use, little is known on the possibly different structural changes PS-substitutions may provoke in DNA·RNA hybrids. Additionally, scarce information and significant controversy exists on the role of phosphorothioate chirality in modulating PS properties. Here, through comprehensive computational investigations and experimental measurements, we shed light on the impact of PS chirality in DNA-based antisense oligonucleotides; how the different phosphorothioate diastereomers impact DNA topology, stability and flexibility to ultimately disclose pro-Sp S and pro-Rp S roles at the catalytic core of DNA Exonuclease and Human Ribonuclease H; two major obstacles in ASOs-based therapies. Altogether, our results provide full-atom and mechanistic insights on the structural aberrations PS-substitutions provoke and explain the origin of nuclease resistance PS-linkages confer to DNA·RNA hybrids; crucial information to improve current ASOs-based therapies.
© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.
Figures







Similar articles
-
Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides.Nucleic Acids Res. 2020 Feb 28;48(4):1691-1700. doi: 10.1093/nar/gkaa031. Nucleic Acids Res. 2020. PMID: 31980820 Free PMC article.
-
Synthesis, biophysical properties and biological activity of second generation antisense oligonucleotides containing chiral phosphorothioate linkages.Nucleic Acids Res. 2014 Dec 16;42(22):13456-68. doi: 10.1093/nar/gku1115. Epub 2014 Nov 14. Nucleic Acids Res. 2014. PMID: 25398895 Free PMC article.
-
Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides.Nucleic Acids Res. 2018 Apr 20;46(7):3579-3594. doi: 10.1093/nar/gky145. Nucleic Acids Res. 2018. PMID: 29514240 Free PMC article.
-
Phosphorothioates, essential components of therapeutic oligonucleotides.Nucleic Acid Ther. 2014 Dec;24(6):374-87. doi: 10.1089/nat.2014.0506. Nucleic Acid Ther. 2014. PMID: 25353652 Review.
-
True antisense oligonucleotides with modified nucleotides restricted in the N-conformation.Curr Top Med Chem. 2007;7(7):661-5. doi: 10.2174/156802607780487768. Curr Top Med Chem. 2007. PMID: 17430207 Review.
Cited by
-
Interaction of Selected Anthracycline and Tetracycline Chemotherapeutics with Poly(I:C) Molecules.ACS Omega. 2025 Apr 15;10(16):15935-15946. doi: 10.1021/acsomega.4c05483. eCollection 2025 Apr 29. ACS Omega. 2025. PMID: 40321536 Free PMC article.
-
Comparative molecular dynamics calculations of duplexation of chemically modified analogs of DNA used for antisense applications.NAR Genom Bioinform. 2024 Nov 28;6(4):lqae155. doi: 10.1093/nargab/lqae155. eCollection 2024 Dec. NAR Genom Bioinform. 2024. PMID: 39633726 Free PMC article.
-
Development of bioconjugate-based delivery systems for nucleic acids.RNA. 2024 Dec 16;31(1):1-13. doi: 10.1261/rna.080273.124. RNA. 2024. PMID: 39477529 Free PMC article. Review.
-
Structural dynamics of therapeutic nucleic acids with phosphorothioate backbone modifications.NAR Genom Bioinform. 2024 May 25;6(2):lqae058. doi: 10.1093/nargab/lqae058. eCollection 2024 Jun. NAR Genom Bioinform. 2024. PMID: 38800826 Free PMC article.
-
G-Quadruplex Conformational Switching for miR-155-3p Detection Using a Ligand-Based Fluorescence Approach.Biomolecules. 2025 Mar 13;15(3):410. doi: 10.3390/biom15030410. Biomolecules. 2025. PMID: 40149946 Free PMC article.
References
-
- Roush W. Antisense aims for a renaissance. Science. 1997; 276:1192–1193. - PubMed
-
- Crooke S.T., Seth P.P., Vickers T.A., Liang X.H.. The interaction of phosphorothioate-containing RNA targeted drugs with proteins is a critical determinant of the therapeutic effects of these agents. J. Am. Chem. Soc. 2020; 142:14754–14771. - PubMed
-
- Perry C.M., Balfour J.A.. Fomivirsen. Drugs. 1999; 57:375–380. - PubMed